Loading…
PCL / β‐AgVO 3 nanocomposites obtained by solvent casting as potential antimicrobial biomaterials
The adhesion of microorganisms on biomaterials can impair its effective application. The addition of antimicrobial agents is a promising alternative to overcome this limitation. In this work, films of polycaprolactone (PCL) and nanostructured β‐AgVO 3 (SV) were produced by solvent casting with 0.1,...
Saved in:
Published in: | Journal of applied polymer science 2021-04, Vol.138 (13) |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The adhesion of microorganisms on biomaterials can impair its effective application. The addition of antimicrobial agents is a promising alternative to overcome this limitation. In this work, films of polycaprolactone (PCL) and nanostructured β‐AgVO
3
(SV) were produced by solvent casting with 0.1, 0.5, and 1.0 wt% of SV. The effect of SV on the structure of PCL was investigate using Fourier transform infrared spectroscopy (FTIR), X‐ray diffraction (XRD), Raman spectroscopy, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). The antimicrobial activity of the films against
Staphylococcus aureus
and
Escherichia coli
was evaluated by the agar diffusion method and by direct contact test. FTIR confirmed the presence of SV into the PCL films, with chemical interaction between them. SEM showed that SV nanorods were well dispersed and with good interfacial adhesion with PCL. XRD diffraction and Raman spectroscopy showed that the presence of SV increased the number of nucleation sites, reducing the size of crystallites and increasing the amorphous domains in the PCL matrix, consequently reducing crystallinity. This behavior was confirmed by DSC, which showed a reduction in the crystallinity with increasing SV content. Films with 1 wt% of SV showed antimicrobial activity against
Staphylococcus aureus
in direct contact test. |
---|---|
ISSN: | 0021-8995 1097-4628 |
DOI: | 10.1002/app.50130 |